Today’s AI Top Pick: TMDX

7/27/2026 · Swing Setup screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Swing SetupTMDXBUY NOW8.6 / 107/27/2026

TransMedics (TMDX) is the cleanest swing setup on the board today: a fundamentally strong medtech that has been washed out on the weekly (-40.94% recent_21bar, dd -40.94%, pos 16.1% of range) but is now flashing multi-timeframe forecast agreement to the upside. All four timeframes point higher — 1h fc +29.16/+29.15/+39.06, 4h fc +49.42/+40.84/+40.92, 1d fc +45.07/+68.52/+53.65, and even the beaten-down 1wk fc turns positive at +4.22/+11.42/+23.54. That is the rare 'all four green' configuration the lens is built to find, with bullish_prob 1.0 and near_term_bullish 1.0. The fundamentals back the tape. TMDX has ROE 45.22, profit margin 27.04%, EPS growth next year of +70.61%, sales YoY +30.24%, PE 16.58, and analyst upside of 56.2% with recom 1.64. Unlike several other high-forecast names on this list (BRZE, KVYO, TTAN, NTSK), TMDX is actually profitable and cash-generative. The only fundamental blemish is debtEq 1.75 and shortFloat 23.23% — the latter is actually a bullish squeeze setup given the forecast alignment. On timing: the 1h is at 94% of range so you don't want to chase a green candle, but the 1d is only 67% of range with a -4% drawdown and the weekly is deeply oversold at 16% of range. That combination — short-term momentum starting, intermediate not extended, long-term oversold — is textbook swing entry. I passed on FUTU (better fundamentals on paper) specifically because of the July 3 DOJ probe / class-action headlines — that is exactly the type of landmine that overrides a screener pass. I also considered BRZE (positive JPM/GS coverage, position 0% of 1h range) but its unprofitability (-15.5% profit margin, -23% ROE) makes it a lower-quality holding than TMDX. The recent Evercore ISI PT cut to $90 (still Outperform) is a mild negative but is already priced in — the stock trades at $72.93, still implying ~23% upside to that lowered target and 56% to consensus. This is a buy today, not tomorrow.

Entry zone

$71.50–$73.50 (current $72.93; add on any dip toward the 1d pos-in-range midpoint near $70)

Stop loss

$67.90 (below the 1d dd_from_21bar_high level, ~7% risk)

First target

$85 (roughly the 1d fc_short implied level, +16.5%)

Longer target

$105–110 (aligns with 1d fc_mid +68.5% / analyst consensus, +44–51%)

Risks

debtEq of 1.75 is elevated vs. peers — any rate/credit tightening hits this name harder
shortFloat 23.23% cuts both ways: squeeze potential but also confirms bearish institutional positioning
Weekly drawdown of -40.94% signals a broken longer-term trend; a failed bounce here could retest lows
Evercore's July 6 PT cut to $90 shows sell-side is trimming expectations even while staying Outperform
1h pos_in_21bar_range at 94% means near-term entries risk buying into an intraday extension

Honorable mentions

BRZEBullish_prob 1, near_term_bullish 1, all 4 TF mid/long forecasts positive (1d +21.75/+14.06, 1wk +25.4/+21.6), position 0% on 1h and 14% on 1d = no chase risk, plus fresh JPM PT raise to $35 and Goldman positive note. Held back only by -15.5% profit margin and -23% ROE.

KVYORecom 1.17 (near strong-buy), Citi just raised PT to $34, all four timeframes forecast positive (1d fc +11.7/+34.9/+37.6), position mid-range on 1d (54%), and targetUpsidePct of 77.1%. Cleaner news backdrop than TMDX but weaker profitability profile (-0.66% margin).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	All 4 TFs green, deep weekly washout, profitable growth compounder — best risk/reward on the board.
2	BRZE	BUY NOW	7.8	Full multi-TF confirmation with position 0% of 1h range = no-chase entry, backed by fresh JPM/GS upgrades.
3	KVYO	BUY NOW	7.4	All-positive forecasts, Citi PT raise to $34, 77% analyst upside, mid-range entry.
4	EQX	BUY NOW	7.1	Recom 1.0, PEG 0.19, fwdPe 6.22, strong 1h/4h forecasts (+39/+50), gold tailwind — weekly forecast is the caveat.
5	SRAD	BUY PULLBACK	6.8	PEG 0.45, EPS +68%, but two PT cuts (Guggenheim, Stifel) and 1h fc negative — wait for confirmation.
6	STEP	BUY PULLBACK	6.6	Multi-TF positive on 1h/4h/1d, near_term_bullish 0.8, but roe -750 (one-off) and PT cut headline.
7	KRMN	BUY PULLBACK	6.4	RBC bullish thesis on H2 acceleration + Walker deal, 4h/1d fc strong (+21/+43/+57), no weekly data.
8	LIF	WAIT	6.2	Fundamentals solid (ROE 30.7, margin 28.2%), BofA and Citi PT raises, but 1h/4h/1wk forecasts turn negative.
9	KC	BUY PULLBACK	6.1	Recom 1.06, targetUpsidePct 102%, 1h/4h/1d forecasts strongly up (+52/+43/+60), but no earnings visibility.
10	FUTU	WAIT	6.0	Best fundamentals on the list but DOJ probe + class-action headlines are a disqualifying landmine for a #1 pick.
11	AVAV	BUY PULLBACK	5.9	Sales YoY +140.9%, 1d fc +51.8/+62, near_term_bullish 1.0, but -13.4% profit margin and 1h stalled.
12	HMY	BUY PULLBACK	5.8	ROE 32.95, PEG 0.09, fwdPe 4.35, but pos 91% on 1h/1d = chasing, and 1wk fc turns -50/-66.
13	KTOS	WAIT	5.7	targetUpsidePct 124.6% and SpaceX narrative, but pe 280, 1wk fc -23/-53, earnings 8/4 is binary.
14	MNDY	WAIT	5.4	20% layoffs headline is a mixed signal; forecast alignment is choppy despite outlier 1wk +169%.
15	CLBT	WAIT	5.3	Recom 1.0, but CEO sold $1.6M and 1h/4h/1wk forecasts turn negative.
16	TTAN	WAIT	5.1	1h/4h forecasts negative, CFO insider sale, -13.4% margin — wait for basing.
17	AGYS	WAIT	5.0	Earnings tomorrow makes this binary; 1h fc -17, 4h fc -3.5, 1wk fc turning down.
18	MNR	WAIT	4.9	Raymond James PT raise but salesYoY only 22.5% and RSI 58.97 (upper edge).
19	SAIL	WAIT	4.7	Entro acquisition + agentic story, but insider selling and short float 33.95% is heavy.
20	CHYM	WAIT	4.6	BMO PT cut to $28, 1h/4h forecasts negative, -44% profit margin.
21	BMNR	AVOID	4.5	Crypto-treasury proxy with -14,335% profit margin and PS 155 — 4h fc positive but structurally toxic.
22	BKV	WAIT	4.4	Cheap (fwdPe 13.6) and profitable, but positions at 0–7% of range on 4h/1d = weak tape.
23	NTSK	AVOID	4.3	fwdPe 538, profit margin -95%, and 1h/1d fc turning down despite Keybanc PT raise.
24	ARIS	AVOID	4.1	Strong ops story but 1d/1wk forecasts turn -15/-51/-72; tape says the run is done.
25	AG	AVOID	3.9	Silver theme but 1d/1wk forecasts collapse (-12/-56/-60), pos 13% 1wk = broken.
26	GLBE	AVOID	3.7	Truist upgrade but bullish_prob 0 and all-timeframe forecasts negative.
27	HAPN	AVOID	3.5	bullish_prob 0, only 2 TFs available, both with negative mid/long forecasts, downgrade headline.
28	DLO	AVOID	3.2	Every single forecast horizon is negative across all four timeframes — screener passes but tape rejects.
29	LC	AVOID	3.0	All forecasts negative on 4h/1d/1wk (-13/-24/-28), pos 86% of 1wk range = distribution.
30	TGB	AVOID	2.9	PE 250, expected_return -24%, screener pass masks a broken setup.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord